Literature DB >> 3504408

GABA and amino acid concentrations in lumbar CSF in patients with treated and untreated epilepsy.

P M Crawford1, D W Chadwick.   

Abstract

Lumbar free CSF GABA and amino acid concentrations were measured in 43 patients with newly diagnosed untreated epilepsy and 26 patients with chronic drug-resistant epilepsy. The results were compared with those from 51 control patients. No differences in free CSF GABA concentration could be detected between patients with epilepsy, either treated or untreated, and controls. Untreated patients with primary generalised epilepsy and partial seizures had similar free CSF GABA concentrations. These results would not support the hypothesis that patients with epilepsy have a global disturbance of GABA function. CSF taurine, asparagine, aspartate, glycine and alanine were significantly reduced in patients with epilepsy compared to the control population.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3504408     DOI: 10.1016/0920-1211(87)90057-x

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  4 in total

1.  Free-GABA levels in the cerebrospinal fluid of patients suffering from several neurological diseases Its potential use for the diagnosis of diseases which course with inflammation and tissular necrosis.

Authors:  A T Zepeda; F J Ortiz Nesme; J Méndez-Franco; E Otero-Siliceo; M Pérez de la Mora
Journal:  Amino Acids       Date:  1995-09       Impact factor: 3.520

Review 2.  Dogs as a Natural Animal Model of Epilepsy.

Authors:  Wolfgang Löscher
Journal:  Front Vet Sci       Date:  2022-06-22

3.  Plasma and cerebrospinal fluid amino acids in epileptic patients.

Authors:  Sirpa Rainesalo; Tapani Keränen; Johanna Palmio; Jukka Peltola; Simo S Oja; Pirjo Saransaari
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

4.  Inhibitory and excitatory amino acids in cerebrospinal fluid of chronic epileptic patients.

Authors:  A Pitkänen; R Matilainen; T Halonen; R Kutvonen; P Hartikainen; P Riekkinen
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.